MXPA03006749A - Proceso para la sintesis de compuestos de urea sustituidos con heteroarilo, utiles como agentes antiinflamatorios. - Google Patents
Proceso para la sintesis de compuestos de urea sustituidos con heteroarilo, utiles como agentes antiinflamatorios.Info
- Publication number
- MXPA03006749A MXPA03006749A MXPA03006749A MXPA03006749A MXPA03006749A MX PA03006749 A MXPA03006749 A MX PA03006749A MX PA03006749 A MXPA03006749 A MX PA03006749A MX PA03006749 A MXPA03006749 A MX PA03006749A MX PA03006749 A MXPA03006749 A MX PA03006749A
- Authority
- MX
- Mexico
- Prior art keywords
- heteroaryl
- urea compounds
- synthesis
- substituted urea
- compounds useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invencion se refiere a nuevos procesos para preparar los compuestos de urea sustituidos con heteroarilo de la formula (I) que son utiles para tratar enfermedades y condiciones patologicas que involucran inflamacion, tales como la enfermedad inflamatoria cronica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26884101P | 2001-02-15 | 2001-02-15 | |
PCT/US2002/002982 WO2002066442A1 (en) | 2001-02-15 | 2002-01-01 | Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03006749A true MXPA03006749A (es) | 2004-05-31 |
Family
ID=23024722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03006749A MXPA03006749A (es) | 2001-02-15 | 2002-01-01 | Proceso para la sintesis de compuestos de urea sustituidos con heteroarilo, utiles como agentes antiinflamatorios. |
Country Status (6)
Country | Link |
---|---|
US (1) | US6916924B2 (es) |
EP (1) | EP1362037A1 (es) |
JP (1) | JP2004518739A (es) |
CA (1) | CA2435446A1 (es) |
MX (1) | MXPA03006749A (es) |
WO (1) | WO2002066442A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2299689T3 (es) | 2002-02-25 | 2008-06-01 | Boehringer Ingelheim Pharmaceuticals Inc. | Compuestos de cicloalquil-uera fusionada con benzo 1,4-disustituido, utiles para el tratamiento de enfermedades por citoquinas. |
US20040138216A1 (en) * | 2002-12-23 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea |
US7144911B2 (en) * | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
AU2004270733B2 (en) | 2003-09-11 | 2011-05-19 | Itherx Pharma, Inc. | Cytokine inhibitors |
JP2007514791A (ja) * | 2003-12-18 | 2007-06-07 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | P38mapキナーゼインヒビターであるbirb796の多形 |
ATE517885T1 (de) * | 2004-04-30 | 2011-08-15 | Bayer Healthcare Llc | Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs |
US20090312349A1 (en) * | 2004-12-23 | 2009-12-17 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
EP2942349A1 (en) | 2004-12-23 | 2015-11-11 | Deciphera Pharmaceuticals, LLC | Enzyme modulators and treatments |
US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
US7790756B2 (en) | 2006-10-11 | 2010-09-07 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
US20110189167A1 (en) * | 2007-04-20 | 2011-08-04 | Flynn Daniel L | Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases |
AU2008242720A1 (en) * | 2007-04-20 | 2008-10-30 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
GB0818033D0 (en) | 2008-10-02 | 2008-11-05 | Respivert Ltd | Novel compound |
NZ591427A (en) | 2008-10-02 | 2012-12-21 | Respivert Ltd | P38 map kinase inhibitors |
MX2011004535A (es) * | 2008-10-29 | 2011-11-18 | Deciphera Pharmaceuticals Llc | Ciclopropanamidas y analogos que exhiben actividades anti-cancer y anti-proliferativas. |
NZ593104A (en) | 2008-12-11 | 2012-11-30 | Respivert Ltd | P38 map kinase inhibitors |
GB0905955D0 (en) | 2009-04-06 | 2009-05-20 | Respivert Ltd | Novel compounds |
US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
CN111818915B (zh) | 2018-01-31 | 2024-05-24 | 德西费拉制药有限责任公司 | 治疗胃肠道间质瘤的组合疗法 |
TW202122082A (zh) | 2019-08-12 | 2021-06-16 | 美商迪賽孚爾製藥有限公司 | 治療胃腸道基質瘤方法 |
AU2020329956B2 (en) | 2019-08-12 | 2023-11-16 | Deciphera Pharmaceuticals, Llc. | Ripretinib for treating gastrointestinal stromal tumors |
JP2023509628A (ja) | 2019-12-30 | 2023-03-09 | デシフェラ・ファーマシューティカルズ,エルエルシー | 1-(4-ブロモ-5-(1-エチル-7-(メチルアミノ)-2-オキソ-1,2-ジヒドロ-1,6-ナフチリジン-3-イル)-2-フルオロフェニル)-3-フェニル尿素の組成物 |
BR112022013109A2 (pt) | 2019-12-30 | 2022-09-06 | Deciphera Pharmaceuticals Llc | Formulações de inibidor de quinase amorfo e métodos de uso das mesmas |
US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1367599A (en) | 1997-11-03 | 1999-05-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aromatic heterocyclic compounds as anti-inflammatory agents |
UA73492C2 (en) | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
DE60014603T2 (de) | 1999-03-12 | 2006-02-16 | Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel |
WO2001004115A2 (en) | 1999-07-09 | 2001-01-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Novel process for synthesis of heteroaryl-substituted urea compounds |
CA2387762C (en) | 1999-10-29 | 2008-07-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | Process of making substituted pyrazoles |
US6635767B2 (en) | 2000-05-23 | 2003-10-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Synthesis of heteroarylamine intermediate compounds |
-
2002
- 2002-01-01 WO PCT/US2002/002982 patent/WO2002066442A1/en active Application Filing
- 2002-01-01 CA CA002435446A patent/CA2435446A1/en not_active Abandoned
- 2002-01-01 EP EP02707665A patent/EP1362037A1/en not_active Withdrawn
- 2002-01-01 MX MXPA03006749A patent/MXPA03006749A/es active IP Right Grant
- 2002-01-01 JP JP2002565959A patent/JP2004518739A/ja active Pending
- 2002-02-12 US US10/074,895 patent/US6916924B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2002066442A1 (en) | 2002-08-29 |
CA2435446A1 (en) | 2002-08-29 |
EP1362037A1 (en) | 2003-11-19 |
US20020123631A1 (en) | 2002-09-05 |
JP2004518739A (ja) | 2004-06-24 |
US6916924B2 (en) | 2005-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03006749A (es) | Proceso para la sintesis de compuestos de urea sustituidos con heteroarilo, utiles como agentes antiinflamatorios. | |
MXPA02000314A (es) | Proceso novedoso para la sintesis de compuestos de urea substituidos con heteroarilo. | |
MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
MXPA04000328A (es) | Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer. | |
TW200512195A (en) | Benzamide 2-hydroxy-3-diaminoalkanes | |
SG162753A1 (en) | Methods of treating cancer and other conditions or disease states using lfmau and ldt | |
MXPA04004301A (es) | Bencimidazoles sustituidos utiles como inhibidores de la proteina cinasa. | |
TW200633977A (en) | Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives | |
ATE386030T1 (de) | 1,4-disubstituierte benzokondensierte cycloalkyl- harnstoffverbindungen zur behandlung von zytokinvermittelten erkrankungen | |
DE60216952D1 (de) | Beta-carbolin-derivate als ptp-inhibitoren | |
BRPI0408369A (pt) | derivados de indol úteis para o tratamento de doenças | |
EA200600122A1 (ru) | Производные пиримидина для лечения патологического роста клеток | |
MXPA04002785A (es) | Aminas sustituidas para tratamiento de enfermedad de alzheimer. | |
TW200505418A (en) | Phenacyl 2-hydroxy-3-diaminoalkanes | |
MXPA04000338A (es) | Diamindioles para tratamiento de enfermedad de alzheimer. | |
NO20051146L (no) | Fremgangsmate for fremstilling av mellomprodukter nyttige for fremstilling av tubulininhibitorer | |
EP1817312A4 (en) | MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER | |
EA200601607A1 (ru) | Сульфонамидные соединения для лечения нейродегенеративных расстройств | |
DE60210614D1 (de) | Für die behandlung von alzheimer krankheit geeignete makrocyclen | |
DE60306193D1 (de) | 1,2,3-triazolamid-derivate als cytokininhibitoren | |
MXPA03011521A (es) | Aminadioles para tratamiento de enfermedad de alzheimer. | |
DE60222286D1 (de) | Verfahren zur erhöhung des testosteronspiegels | |
UA66866C2 (uk) | Синтез морфолінових похідних | |
MXPA04000337A (es) | Amindioles para tratamiento de enfermedad de alzheimer. | |
WO2004029019A8 (en) | Compounds for the treatment of alzheimer’s disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |